Clinical Trials · NCT07460752
Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 98
- Start date
- Mar 2026
- Locations
- 1 site, United States
- Primary endpoint
- Ovarian function suppression (OFS) maintenance